Keywords: gsk, files, avandia, japan, glaxosmithkline, filed, application

GSK files Avandia in Japan

Article | 18 February 2002

GlaxoSmithKline has filed an application with Japan's Ministry of HealthLabor and Welfare to market Avandia (rosiglitazone) for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

GlaxoSmithKline

GSK

Lilly

Go to company listing

Related Drugs

Avandia

rosiglitazone

Actos

Pioglitazone

Go to drug listing